Sponsor Pipeline

Vergent Bioscience, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07499674 Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in… Lung Cancer Recruiting
Disease Areas
Lung Cancer (1)
Get alerts when Vergent Bioscience, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free